VSCO’s Turnaround Validated, But Valuation Now the Key Risk

What happened

In late 2025, Victoria’s Secret was viewed as a risk-aware BUY at roughly 10.8x forward earnings, with a credible turnaround under new leadership and stabilizing comps, but facing tariff and competition headwinds. By September 2026, the stock has more than doubled to $74.80 and now trades at 21.68x earnings, well above its prior discount to branded retail peers. A recent earnings release saw the company beat Wall Street estimates comfortably, yet the stock declined, signaling a shift in market focus from fundamental recovery to valuation and expectations. The article title suggests the operational comeback is real, but the stock’s problem is different—likely that the re-rating has already occurred and even good news is insufficient to drive further upside. This marks a major departure from the original buy thesis, where the stock offered a margin of safety based on undervaluation relative to peers.

Implication

The surge from $29 to $75 reflects strong confidence in management’s execution and the success of the Path to Potential strategy, but it also borrows from future growth. The recent earnings reaction—a comfortable beat met with a price decline—indicates that the market is now more sensitive to guidance, growth sustainability, or margin trajectory than to headline numbers. At 21.68x P/E, VSCO trades at a premium to its historical range and above many specialty retailers, leaving little room for error if tariffs or competition intensify. For investors who purchased at lower valuations, this may be an opportune time to reassess position sizing or take profits, while new investors should demand stronger evidence of continued growth before committing capital. Critical monitoring points now shift from proof-of-turnaround to proof-of-sustainability, including comp sales consistency, gross margin recapture, and successful international scaling without margin dilution.

Thesis delta

The original BUY thesis was predicated on an undervalued multiple (~10.8x P/E) relative to peers, with upside from execution and re-rating. As of September 2026, the re-rating has occurred, with the multiple expanding to 21.68x and the stock price more than doubling. Consequently, the thesis shifts from “undervalued turnaround” to “fairly or fully valued turnaround,” and the stance would likely be downgraded to HOLD or SELL unless new growth catalysts emerge that justify the current valuation.